✓ Plata cu cardul restabilită — finalizare securizată prin Privacy Shield

Amlip

Amlip is Cipla’s amlodipine 2.5 / 5 mg tablets — starter-to-maintenance DHP calcium-channel blocker. 2.5 mg is the low-starter strength for elderly, small body size, or hepatic impairment. 5 mg is standard maintenance for hypertension and angina. Once daily; gradual smooth onset; no reflex tachycardia.

Verificat medical de Morgan Ellis — Cercetător farmaceutic · 8 ani de experiență  · Ultima recenzie: mai 2026

Cumpără mai mult, economisește mai mult Preț pe tabletă
Selectați o doză mai sus pentru a vedea prețurile pachetelor.
Plată criptată
Plățile în crypto reduc prețul cu 10%
Livrare discretă în întreaga lume
1.400+ clienți · 50+ țări

⚡ Quick Answer — What is Amlip?

Amlip este un 2.5 / 5 mg amlodipine tablet from Cipla — a third-generation dihydropyridine calcium-channel blocker (CCB). Introduced 1990 (Pfizer as Norvasc / Istin). The reference DHP for hypertension worldwide. Plasma half-life 35-50 hours — the longest of any CCB and one of the longest half-lives in cardiovascular medicine. Amlodipine’s extremely long half-life means: (1) dose missed by a day has minimal effect, (2) gradual smooth onset with no reflex tachycardia (unlike short-acting nifedipine), (3) no need for sustained-release formulations, (4) can be paired safely with any other antihypertensive class including beta-blockers. Typical hypertension dose: 5 mg once daily (2.5 mg if elderly, small body size, or hepatic impairment); target 5-10 mg once daily. Main side effects: ankle (peripheral) oedema, flushing, headache from vasodilation, reflex tachycardia (blunted by amlodipine’s long half-life; common with IR nifedipine). Safe to combine with beta-blockers, ACE inhibitors, ARBs, and thiazides (unlike non-DHP CCBs). Pregnancy: nifedipine MR is pregnancy-safe and often first-line; amlodipine is reasonable second option.

Ce beneficii oferă MedsBase: Producător certificat WHO-GMP · Ambalaj discret · Livrare la nivel mondial · Peste 1.400 de recenzii verificate ale clienților

📦 Fiecare comandă este acoperită de politica noastră de Politica noastră de Reexpediere Garantată — dacă coletul dumneavoastră nu sosește în 20 de zile lucrătoare, îl relivrăm.

De ce să comanzi de la MedsBase

Medicamentele noastre generice sunt procurate de la producători certificați WHO-GMP și expediate la nivel mondial în ambalaje discrete și simple — fără denumirea medicamentului pe exteriorul coletului. Plățile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de plăți cu card reglementat — niciodată “MedsBase” sau numele vreunui medicament). Acceptăm și criptomonede și transferuri bancare SEPA. Fiecare comandă este susținută de Politica noastră de Asigurare pentru Relivrare.

What Is Amlip?

Amlip is an oral 2.5 / 5 mg amlodipine tablet from Cipla, supplied in 30-180 tablets. Introduced 1990 (Pfizer as Norvasc / Istin). The reference DHP for hypertension worldwide.

Amlodipine belongs to the dihydropyridine calcium-channel blocker subclass, distinguished from the non-dihydropyridines (diltiazem, verapamil) by its selective action on vascular smooth muscle with minimal direct cardiac effect. This selectivity profile is clinically important: DHPs can be combined safely with beta-blockers (the combination is standard in angina), while non-DHPs cannot (additive bradycardia/heart-block risk).

How Amlodipine Works

Calcium-channel blockers bind L-type voltage-gated calcium channels and reduce calcium influx into the cell during depolarisation. In arterial smooth muscle, reduced calcium entry means less actin-myosin interaction and direct arterial vasodilation — lowering systemic vascular resistance and blood pressure.

Dihydropyridines are ~10-fold more potent on vascular smooth muscle than on cardiac muscle — so the dominant clinical effect is vasodilation, with minimal direct suppression of cardiac contractility or conduction. The body’s baroreflex can trigger mild reflex tachycardia after fast-onset vasodilation; amlodipine’s very long onset eliminates this effect clinically.

Onset of clinical effect: gradual onset over 6-12 hours, full effect at 7-8 days.

Approved and Evidence-Based Uses

  • Uncomplicated hypertension — often first-line, particularly for Black patients and those over 55 (NICE, AHA)
  • Hypertension + stable angina (dual indication)
  • Prinzmetal / vasospastic angina — first-line
  • Raynaud’s phenomenon
  • Hypertension in heart failure with preserved ejection fraction (HF-pEF) — safer than non-DHP CCBs which are contraindicated in HF-REF
  • Hypertension in pregnancy — not first-line but reasonable second option after methyldopa / labetalol / nifedipine MR

Pivotal trial evidence: ASCOT-BPLA (2005) — perindopril + amlodipine beat atenolol + thiazide for CV outcomes in hypertension, establishing the modern preference for CCB + ACEi/ARB over beta-blocker + thiazide. VALUE (2004) — amlodipine-based therapy had slight advantage over valsartan-based therapy on stroke+MI endpoints, driven largely by faster BP drop. ALLHAT (2002) — amlodipine equivalent to chlorthalidone for most outcomes, better than lisinopril for stroke in black patients.

Amlip Dosage

Hypertension:

  • Starting dose: 5 mg once daily (2.5 mg if elderly, small body size, or hepatic impairment)
  • Target dose: 5-10 mg once daily
  • Maximum: 10 mg once daily
  • Titrate every 1-2 weeks based on BP response and tolerability (particularly oedema)

Angina: 5-10 mg once daily for chronic stable and vasospastic angina

Administration: once daily (or twice daily for IR nifedipine formulations). Swallow whole — do NOT crush or split extended-release formulations (delivers an IR dose with risk of hypotension). Take with or without food.

Discontinuation: no specific withdrawal syndrome; can be stopped without taper. BP will return to pre-treatment levels within 1-2 weeks.

Efecte Secundare

Common (>5%, mostly mild and transient):

  • Peripheral (ankle) oedema — Peripheral (ankle) oedema from pre-capillary vasodilation — dose-related (up to 25% at 10 mg/day). Not from fluid overload; does not respond to diuretics. Management: reduce dose, combine with an ACE inhibitor or ARB (which neutralise the oedema via balanced pre-and-post-capillary vasodilation), or switch to a non-DHP CCB (diltiazem, verapamil) if the heart-rate effect is acceptable.
  • Flushing (warm face and upper body)
  • Headache (particularly at start of therapy; usually adapts within 2-4 weeks)
  • Minor palpitations (less common than with short-acting nifedipine)
  • Dizziness, postural hypotension
  • Oboseală
  • Mild constipation (less than non-DHPs)

Mai puțin frecvente:

  • Rash, pruritus
  • Nausea, abdominal discomfort
  • Erectile dysfunction (rare)
  • Liver enzyme elevations (usually mild, reversible)
  • Rare reports of photosensitivity

Contraindications & Cautions

  • Known hypersensitivity to amlodipine or dihydropyridine class
  • Cardiogenic shock
  • Severe aortic stenosis (can cause critical hypotension)
  • Unstable angina or MI within 1 month (DHPs other than amlodipine)
  • Obstructive hypertrophic cardiomyopathy (reduces outflow gradient dynamically)
  • Severe hepatic impairment (all DHPs are hepatically metabolised)

Pregnancy: amlodipine is not first-line in pregnancy but has reassuring observational data; a reasonable second-line choice if labetalol, methyldopa, and nifedipine MR are ineffective or contraindicated.

Breastfeeding: small amounts in breast milk; generally considered acceptable with infant monitoring.

Interacțiuni medicamentoase

  • Suc de grapefruit — inhibits CYP3A4 metabolism; can raise plasma levels of amlodipine and particularly nifedipine/nimodipine by 2-3×. Avoid on treatment days, or use consistently if at all.
  • Inhibitori puternici ai CYP3A4 (ketoconazole, itraconazole, clarithromycin, ritonavir, cobicistat) — raise CCB plasma levels; reduce dose or avoid
  • Strong CYP3A4 inducers (rifampicin, phenytoin, carbamazepine, St John’s wort) — reduce CCB plasma levels; may need dose increase
  • Simvastatin — amlodipine modestly increases simvastatin exposure; cap simvastatin at 20 mg/day when combined
  • Beta-blockers — DHPs combine safely with beta-blockers (the combination is standard in angina — beta-blocker blunts reflex tachycardia, CCB provides vasodilation). Distinct from non-DHP CCBs (diltiazem, verapamil) which should NOT be combined with beta-blockers.
  • Other antihypertensives — generally complementary; monitor BP
  • Sildenafil / tadalafil (PDE5 inhibitors for erectile dysfunction) — additive hypotension; caution particularly at high CCB doses

Calcium-Channel Blocker Class at a Glance

CCBClassNiche
Amlodipine (Amlode, Amlip)DHP (3rd gen)Reference DHP; once-daily HTN + angina; ASCOT evidence
Nifedipine (Depin, Nicardia Retard, Cardipin)DHP (1st gen)Pregnancy-safe MR; tocolysis; must use ER formulations for chronic HTN
Nimodipine (Nimodip)DHP (cerebrovascular)Subarachnoid haemorrhage vasospasm prevention — NOT for routine HTN
Diltiazem (Dilzem, Dilzem CD)Non-DHP (benzothiazepine)HTN + rate control + angina; moderate cardiac effect
Verapamil (Calaptin 40, Calaptin SR)Non-DHP (phenylalkylamine)Strongest cardiac effect; SVT, AF rate, cluster headache

DHP vs non-DHP — why it matters: DHPs (amlodipine, nifedipine) act selectively on arterial smooth muscle with minimal cardiac effect — safe to combine with beta-blockers. Non-DHPs (diltiazem, verapamil) slow AV nodal conduction and reduce cardiac contractility — do NOT combine with beta-blockers (additive bradycardia, heart block, acute heart failure risk). If your patient is already on a beta-blocker, use a DHP.

Depozitare

Store Amlip below 25°C. Protect from light. Keep out of reach of children.

Întrebări frecvente

Why have my ankles started swelling after Amlip?

Peripheral oedema is a class effect of dihydropyridines, caused by pre-capillary arteriolar dilation that raises hydrostatic pressure in the lower-leg venules. It is NOT fluid overload and does NOT respond to diuretics. Management options: (1) reduce the CCB dose; (2) add an ACE inhibitor or ARB which balances pre- and post-capillary vasodilation and eliminates the oedema mechanism (often the preferred solution); (3) switch to a non-DHP CCB (diltiazem, verapamil) if rate-related side effects are acceptable; (4) leg elevation and compression stockings as adjuncts.

How long does Amlip take to lower blood pressure?

Gradual onset — measurable BP reduction within 24-48 hours; full effect at 7-8 days. Amlodipine’s extremely long half-life (35-50 h) gives one of the smoothest BP profiles in cardiovascular medicine.

Can I take Amlip with a beta-blocker?

Yes — DHPs combine safely with beta-blockers. The combination is standard in angina: the DHP vasodilates and reduces myocardial oxygen demand; the beta-blocker blunts the reflex tachycardia. This is different from non-DHP CCBs (diltiazem, verapamil) which should NOT be combined with beta-blockers due to additive bradycardia and heart-block risk.

Can I eat grapefruit on Amlip?

Grapefruit (juice and fresh fruit) inhibits CYP3A4 metabolism and can raise amlodipine plasma levels by 2-3×, increasing the risk of hypotension, dizziness, and oedema. Best practice: avoid grapefruit/juice while on CCBs, or consume consistently (your dose is titrated to BP response; sporadic grapefruit disrupts that).

Is Amlip safe in pregnancy?

Amlodipine is not first-line in pregnancy but has reassuring observational data; a reasonable second-line if labetalol, methyldopa, and nifedipine MR are ineffective or contraindicated. Discuss with your obstetrician.

Can I combine Amlip with my other BP medications?

Yes — DHP CCBs combine well with Inhibitori ACE (ramipril, lisinopril), ARBs (losartan, telmisartan, olmesartan), beta-blockers (bisoprolol, metoprolol), and thiazide diuretics (HCTZ). The ACEi/ARB + CCB combination is particularly useful because it eliminates the ankle oedema side effect.

Where can I buy Amlip online?

You can buy Amlip (amlodipine 2.5 / 5 mg, 30-180 tablets) from MedsBase with discreet packaging and worldwide shipping.

Related Antihypertensives on MedsBase

⚕ Dezaprobare medicală. This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. Hypertension, heart failure, and arrhythmias require diagnosis, monitoring, and dose individualisation by a doctor — always use beta-blockers under medical guidance.

Alternative conexe

Alte produse din Afecțiuni cronice pe care clienții le vizualizează de asemenea:

Mai multe opțiuni în medicamente pentru hipertensiune arterială

Clasificate în funcție de volumul recent de comenzi MedsBase — ce aleg alți clienți în această categorie.

Concentrație

2.5 mg, 5 mg

Cantitate

30 Comprimat/e, 60 Comprimat/e, 90 Comprimat/e, 180 Comprimat/e

Recenzii

Nu există recenzii încă

Adăugați o recenzie
Amlip Amlip
Evaluare*
0/5
* Evaluarea este obligatorie
* Răspunsul este obligatoriu
Recenzia dvs.
* Recenzia este obligatorie
Nume
* Numele este obligatoriu
Adăugați fotografii sau videoclip la recenzia dvs.

Întrebări și răspunsuri

Pune o întrebare
Amlip Amlip
Întrebarea ta
* Întrebarea este obligatorie
Nume
* Numele este obligatoriu
Nu există întrebări încă